Turning Point Therapeutics

Turning Point Therapeutics, Inc. is a San Diego-based clinical-stage drug design company that specializes in the discovery and development of targeted cancer therapies designed to address treatment resistance. The company focus is on the design of novel chemical identities for established oncogene drivers with secondary resistant mutations, newly identified disease-driven targets, and potential targets regulating tumor microenvironment and tumor immunity.